Effects of proximal gut bypass on glucose tolerance and insulin sensitivity in humans

Diabetes Care

Volumn 36, Issue 4, 2013, Pages

  Breitman, Igal ^a   Isbell, James M ^a   Saliba, Jabbar ^a   Jabbour, Kareem ^a   Flynn, Charles Robb ^a   Marks Shulman, Pamela A ^a   Laferrère, Blandine ^b   Abumrad, Naji N ^a   Tamboli, Robyn A ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE;

ADULT; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INTESTINE BYPASS; JEJUNUM; LETTER; MALE; NOSE FEEDING; OBESITY; PROXIMAL GUT BYPASS;

BLOOD GLUCOSE; FEMALE; GASTRIC BYPASS; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY;

EID: 84875464073     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1722     Document Type: Letter

References (4)

1. Hare KJ, Vilsbøll T, Holst JJ, Knop FK. Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 2010;298:E832-E837
2. NauckM, Stöckmann F, Ebert R, Creutzfeldt W. Reduced incretin effect in type 2 (noninsulin-dependent) diabetes. Diabetologia 1986;29:46-52
3. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 2001;24:539-548
4. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470